No Data
No Data
April Could Deliver Stock Gains but Dismal Q1 May Foreshadow Weak 2025
CVS, COR, Among Top S&P 500 Healthcare Gainers in Q1; WST and MRNA Among Losers
S&P 500 Exits Q1 in the Red - Here Are Its Largest Losers and Winners
How Is The Market Feeling About West Pharmaceutical Servs?
Evercore Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Maintains Target Price $275
Best & Worst Stock Performers in Each S&P Sector as Q1 Comes to a Close